Literature DB >> 11830176

Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala.

Tammy J Sajdyk1, Douglas A Schober, David L Smiley, Donald R Gehlert.   

Abstract

The behavioral effects of direct injection of the neuropeptide Y (NPY) Y2 receptor agonist C2-NPY into the basolateral nucleus of the amygdala (BLA) was assessed in rats utilizing the social interaction test (SI). C2-NPY decreased SI time in a dose-dependent manner with a significant change observed at a dose of 80 pmol/100 nl. The anxiogenic effects produced by intra-amygdalar C2-NPY injections were reversed with intraperitoneal administration of alprazolam (1 mg/kg), a known anxiolytic. These findings support the hypothesis that Y2 receptors are involved in the regulation of the anxiety response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11830176     DOI: 10.1016/s0091-3057(01)00679-7

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  29 in total

1.  The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression.

Authors:  Ramon O Tasan; Ngoc Khoi Nguyen; Stefan Weger; Simone B Sartori; Nicolas Singewald; Regine Heilbronn; Herbert Herzog; Günther Sperk
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

Review 2.  Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y.

Authors:  Mallory E Bowers; Dennis C Choi; Kerry J Ressler
Journal:  Physiol Behav       Date:  2012-03-10

3.  NPY2 Receptors Reduce Tonic Action Potential-Independent GABAB Currents in the Basolateral Amygdala.

Authors:  James P Mackay; Maria Bompolaki; M Regina DeJoseph; Sheldon D Michaelson; Janice H Urban; William F Colmers
Journal:  J Neurosci       Date:  2019-04-10       Impact factor: 6.167

Review 4.  Neuropeptide Y (NPY) in the extended amygdala is recruited during the transition to alcohol dependence.

Authors:  Nicholas W Gilpin
Journal:  Neuropeptides       Date:  2012-08-29       Impact factor: 3.286

5.  Countervailing modulation of Ih by neuropeptide Y and corticotrophin-releasing factor in basolateral amygdala as a possible mechanism for their effects on stress-related behaviors.

Authors:  Chantelle J Giesbrecht; James P Mackay; Heika B Silveira; Janice H Urban; William F Colmers
Journal:  J Neurosci       Date:  2010-12-15       Impact factor: 6.167

6.  Effect of neuropeptide Y Y2 receptor deletion on emotional stress-induced neuronal activation in mice.

Authors:  Ngoc Khoi Nguyen; Simone B Sartori; Herbert Herzog; Ramon Tasan; Günther Sperk; Nicolas Singewald
Journal:  Synapse       Date:  2009-03       Impact factor: 2.562

7.  The role of neuropeptide Y in the expression and extinction of fear-potentiated startle.

Authors:  Alisa R Gutman; Yong Yang; Kerry J Ressler; Michael Davis
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

8.  Neuropeptide Y receptor gene expression in the primate amygdala predicts anxious temperament and brain metabolism.

Authors:  Patrick H Roseboom; Steven A Nanda; Andrew S Fox; Jonathan A Oler; Alexander J Shackman; Steven E Shelton; Richard J Davidson; Ned H Kalin
Journal:  Biol Psychiatry       Date:  2013-11-15       Impact factor: 13.382

9.  Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice.

Authors:  R O Tasan; S Lin; A Hetzenauer; N Singewald; H Herzog; G Sperk
Journal:  Neuroscience       Date:  2008-12-09       Impact factor: 3.590

Review 10.  Neuropeptide and sigma receptors as novel therapeutic targets for the pharmacotherapy of depression.

Authors:  Konstantinos A Paschos; Stavroula Veletza; Ekaterini Chatzaki
Journal:  CNS Drugs       Date:  2009-09       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.